These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 32036246)

  • 1. Generation of an induced pluripotent stem cell line SYSUi-003-A from a child with epilepsy carrying GRIN2A mutation.
    Sun C; Yang M; Qin F; Guo R; Liang S; Hu H
    Stem Cell Res; 2020 Mar; 43():101706. PubMed ID: 32036246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of an induced pluripotent stem cell line SYSUi-004-A from a child of microcephaly with TYW1 mutations.
    Sun C; Zhou P; Yuan S; Guo R; Zhang Z; Xu Q; Han D; He L; Tang H; Xu K; Hu H; Li N
    Stem Cell Res; 2020 May; 45():101783. PubMed ID: 32279010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of two induced pluripotent stem cells lines from a Mucopolysaccharydosis IIIB (MPSIIIB) patient.
    Vallejo-Diez S; Fleischer A; Martín-Fernández JM; Sánchez-Gilabert A; Bachiller D
    Stem Cell Res; 2018 Dec; 33():180-184. PubMed ID: 30408744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of a human induced pluripotent stem cell line from an epilepsy patient carrying mutations in the PIK3R2 gene.
    Zhang B; Wang Y; Peng J; Hao Y; Guan Y
    Stem Cell Res; 2020 Apr; 44():101711. PubMed ID: 32155459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of an induced pluripotent stem cell line (UBCi001-A) from a presymptomatic individual carrying the R418X progranulin gene mutation.
    Frew J; Wu X; Hsiung GY; Feldman HH; Mackenzie IR; Nygaard HB
    Stem Cell Res; 2019 Dec; 41():101582. PubMed ID: 31707213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of a human induced pluripotent stem cell line (SDUBMSi001-A) from a hereditary spastic paraplegia patient carrying kif1a c.773C>T missense mutation.
    Xiaojing W; Yanyan M; Ruonan D; Xiaolin L; Haiyan Z; Jian M; Yi L; Wenjie S; Qiji L
    Stem Cell Res; 2020 Mar; 43():101727. PubMed ID: 32045731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of human induced pluripotent stem cells (EURACi001-A, EURACi002-A, EURACi003-A) from peripheral blood mononuclear cells of three patients carrying mutations in the CAV3 gene.
    Meraviglia V; Benzoni P; Landi S; Murano C; Langione M; Motta BM; Baratto S; Silipigni R; Di Segni M; Pramstaller PP; DiFrancesco D; Gazzerro E; Barbuti A; Rossini A
    Stem Cell Res; 2018 Mar; 27():25-29. PubMed ID: 29304398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a human induced pluripotent stem cell line (FDCHi015-A) derived from PBMCs of a patient harbouring ALDOB mutation.
    Yin T; Liao Y; Li X; Wang H; Wu B; Dong X
    Stem Cell Res; 2024 Aug; 78():103451. PubMed ID: 38820866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of an induced pluripotent stem cell (iPSC) line from a patient with GEFS+ carrying a STX1B (p.Lys45delinsArgMetCysIleGlu and p.Leu46Met) mutation.
    Haag C; Uysal B; Marquetand J; Löffler H; Mau-Holzmann UA; Lerche H; Schwarz N
    Stem Cell Res; 2023 Mar; 67():103028. PubMed ID: 36652844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of an induced pluripotent stem cell line, ICGi014-A, by reprogramming peripheral blood mononuclear cells from a patient with homozygous D90A mutation in SOD1 causing Amyotrophic lateral sclerosis.
    Ustyantseva EI; Medvedev SP; Vetchinova AS; Illarioshkin SN; Leonov SV; Zakian SM
    Stem Cell Res; 2020 Jan; 42():101675. PubMed ID: 31830646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of an integration-free induced pluripotent stem cell line (LZUSHI001-A) from an epileptic patient with DGKG mutation.
    Liu YQ; Ling TW; Wang HY; Yang YH; Song WJ; Wang TC
    Stem Cell Res; 2022 May; 61():102768. PubMed ID: 35421845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Derivation of an induced pluripotent stem cell line (FDCHi014-A) from PBMCs of a seven-year-old patient with a truncating NOVA2 variant (c.625del).
    Yin T; Qian Y; Zhang X; Liao Y; Wu B; Wang S; Wang H
    Stem Cell Res; 2024 Apr; 76():103369. PubMed ID: 38430735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of integration-free induced pluripotent stem cells from a patient with Familial Mediterranean Fever (FMF).
    Fidan K; Kavaklıoğlu G; Ebrahimi A; Özlü C; Ay NZ; Ruacan A; Gül A; Önder TT
    Stem Cell Res; 2015 Nov; 15(3):694-6. PubMed ID: 26987928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induced pluripotent stem cells (SHCDNi006-A cells) isolated from the peripheral blood mononuclear cells of a five-month-old Chinese girl with the heterozygous missense mutation (c.2800 G>A) in the KCNT1 gene.
    Luo X; Wang Y; Yuan F; Lin L; Wang A; Wang C; Guo M; Wang S; Wang C; Xu Q; Yin R; Cheng H; Zhang Y; Liu Z; Xu W; Yan J; Zeng F; Chen Y
    Stem Cell Res; 2022 Jul; 62():102798. PubMed ID: 35537242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of induced pluripotent stem cell line ICGi018-A from peripheral blood mononuclear cells of a patient with Huntington's disease.
    Malakhova AA; Grigor'eva EV; Malankhanova TB; Pavlova SV; Valetdinova KR; Abramycheva NY; Vetchinova AS; Illarioshkin SN; Zakian SM
    Stem Cell Res; 2020 Apr; 44():101743. PubMed ID: 32179492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of an induced pluripotent stem cell line GWCMCi006-A from a patient with autosomal dominant neurodevelopmental disorder with or without hyperkinetic movements and seizures harboring GRIN1 c.389A > G mutation.
    Shi Z; Liu H; Feng F; Huang Z; Chen WX
    Stem Cell Res; 2024 Apr; 76():103371. PubMed ID: 38452705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral blood derived induced pluripotent stem cells (iPSCs) from a female with familial hypertrophic cardiomyopathy.
    Ross SB; Fraser ST; Bagnall RD; Semsarian C
    Stem Cell Res; 2017 Apr; 20():76-79. PubMed ID: 28395744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment of a transgene-free iPS cell line (SDCHi003-A) from a young patient bearing a NPRL2 mutation and suffering from Epilepsy.
    Su S; Zhao F; Zhang H; Liu Y; Li Z; Zhang H; Wang Y; Fang F; Liu Y
    Stem Cell Res; 2024 Apr; 76():103366. PubMed ID: 38430737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing the method for generation of integration-free induced pluripotent stem cells from human peripheral blood.
    Gu H; Huang X; Xu J; Song L; Liu S; Zhang XB; Yuan W; Li Y
    Stem Cell Res Ther; 2018 Jun; 9(1):163. PubMed ID: 29907164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of an induced pluripotent stem cell line, ICGi029-A, by reprogramming peripheral blood mononuclear cells of a patient suffering from hypertrophic cardiomyopathy and carrying a heterozygous p.N515del mutation in MYBPC3.
    Dementyeva EV; Pavlova SV; Chernyavsky AM; Zakian SM
    Stem Cell Res; 2021 May; 53():102344. PubMed ID: 33892289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.